CMS
65
5
LRCX
71
-6
VLO
35
2
CPB
44
4
BA
45
3
K
33
3
EMN
69
6
BRK.B
42
2
CMI
65
3
CF
42
6
FITB
50
2
MUR
43
17
WU
30
6
CRM
54
-3
MCD
59
13
INTU
66
-3
KSS
51
8
SEE
42
2
CINF
53
6
UAL
38
4
CMS
65
5
LRCX
71
-6
VLO
35
2
CPB
44
4
BA
45
3
K
33
3
EMN
69
6
BRK.B
42
2
CMI
65
3
CF
42
6
FITB
50
2
MUR
43
17
WU
30
6
CRM
54
-3
MCD
59
13
INTU
66
-3
KSS
51
8
SEE
42
2
CINF
53
6
UAL
38
4
Financhill
Back

National Bank Holdings Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
35

NBHC
National Bank Holdings

Last Price:
37.42
Seasonality Move:
1.61%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Sell
35
National Bank Holdings (NBHC) is a Sell

Is National Bank Holdings a Buy, Sell or Hold?

  • The current National Bank Holdings [NBHC] share price is $37.43. The Score for NBHC is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • NBHC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.82. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NBHC Stock Price Chart

What is National Bank Holdings's stock price today?

  • The National Bank Holdings share price today is $37.43
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBHC is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

NBHC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.4 Buy
Relative Strength Index (14 RSI): 61.33 Buy
Chaikin Money Flow: 18341 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.22 - 37.14) Buy
Bollinger Bands (100): (33.53 - 36.21) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.7 Sell
Relative Strength Index (14 RSI): 46.74 Sell
Chaikin Money Flow: 84619 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.82 - 42.02) Sell
Bollinger Bands (100): (40.86 - 48.8) Sell

NBHC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.91 Buy
20-day SMA: 36.62 Buy
50-day SMA: 35.52 Buy
200-day SMA: 33.99 Buy
8-day EMA: 37.04 Buy
20-day EMA: 36.65 Buy
50-day EMA: 35.93 Buy
200-day EMA: 34.81 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.53 Buy
20-day SMA: 40.36 Sell
50-day SMA: 41.57 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.71 Buy
20-day EMA: 40.38 Sell
50-day EMA: 41.84 Sell
200-day EMA: 43.38 Sell

National Bank Holdings Earnings Growth & NBHC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.63 per share, and an increase next year of $0.20 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

National Bank Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):